Candriam Equities L Biotechnology, V - Capitalisation/ LU0317020203 /
| NAV4/16/2025 | Chg.-27.7500 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 1,840.2900USD | -1.49% | reinvestment | Equity | Candriam ▶ |
Funds documents
| Date | Document | Year | Language | Filesize |
|---|---|---|---|---|
| 4/19/2025 | Public WebStation Live Factsheet | 2025 | English | - |
| 2/28/2025 | PRIIP Key Information Document | 2025 | English | 260.66 KB |
| 2/28/2025 | PRIIP Key Information Document | 2025 | German | 269.20 KB |
| 2/5/2025 | Prospectus | 2025 | German | 8,043.87 KB |
| 2/5/2025 | Prospectus | 2025 | English | 6,674.43 KB |
| 6/30/2024 | Semi-annual report | 2024 | German | 2,233.87 KB |
| 6/30/2024 | Semi-annual report | 2024 | English | 2,123.71 KB |
| 12/31/2023 | Account statement | 2023 | English | 5,416.37 KB |
| 12/31/2023 | Account statement | 2023 | German | 4,732.66 KB |
| 7/2/2022 | Key Investor Information | 2022 | German | 361.71 KB |
